Jan 8, 2025 | False Claims Act, Fraud Investigations
Although False Claims Act cases involving federal grant fraud may not be as common as those involving healthcare fraud, the consequences of such cases can be just as significant. Recently, Athira Pharma, a Washington state-based biopharmaceutical company, agreed to...
Oct 14, 2024 | False Claims Act, Health Care, Health Care Fraud, White Collar Crime
On October 10, 2024, the DOJ announced that Teva Pharmaceuticals had agreed to pay $450 million to resolve two matters, one of which was the result of an investigation conducted pursuant to the False Claims Act (FCA). According to the DOJ, the settlement encompasses...
Sep 15, 2024 | DOJ, False Claims Act, Fraud Investigations, Health Care, Medicare and Medicaid
Late last week, the Department of Justice announced that Walgreen had agreed to pay over $106 million to resolve allegations that it violated the False Claims Act by billing government health care programs for prescriptions that were never dispensed. According to the...
Sep 9, 2024 | False Claims Act, Health Care, Health Care Fraud, Medicare and Medicaid
Late last month, the DOJ announced that St. Peter’s Health agreed to pay $10.8M to settle False Claims Act allegations. The settlement resolves claims that the organization submitted inaccurate information to federal healthcare programs, including Medicare and...
Aug 28, 2024 | False Claims Act
On August 26, 2024, the United States Department of Justice announced that the City of Los Angeles agreed to pay $38.2 million to resolve allegations that it knowingly failed to meet federal accessibility requirements when it sought and used HUD grant funds for...
